Citius Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Citius Pharmaceuticals, Inc. (CTXR) reported Earnings Per Share, Basic and Diluted of -$0.06 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-10
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.06.
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.03.
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.05.
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.04.
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.23.
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.45.
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.77.
- Citius Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.17.
| Period end | Earnings Per Share, Basic and Diluted 1 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.06 10-Q · filed 2022-02-10 | ||||||||
| 2021-09-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-12-22 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-12-22 | -$0.23 10-K · filed 2021-12-15 | ||||||
| 2021-06-30 | -$0.05 10-Q · filed 2021-08-12 | -$0.20 10-Q · filed 2021-08-12 | |||||||
| 2021-03-31 | -$0.04 10-Q · filed 2021-05-13 | -$0.16 10-Q · filed 2021-05-13 | |||||||
| 2020-12-31 | -$0.15 10-Q · filed 2022-02-10 | ||||||||
| 2020-09-30 | -$0.08 derived: net income ÷ weighted average shares · filed 2021-12-15 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-12-15 | -$0.45 10-K · filed 2021-12-15 | ||||||
| 2020-06-30 | -$0.11 10-Q · filed 2021-08-12 | -$0.38 10-Q · filed 2021-08-12 | |||||||
| 2020-03-31 | -$0.13 10-Q · filed 2021-05-13 | -$0.28 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | -$0.15 10-Q · filed 2021-02-11 | ||||||||
| 2019-09-30 | -$0.77 10-K · filed 2020-12-16 | ||||||||
| 2019-06-30 | -$0.20 10-Q · filed 2020-08-14 | -$0.61 10-Q · filed 2020-08-14 | |||||||
| 2019-03-31 | -$0.20 10-Q · filed 2020-05-14 | -$0.41 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | -$0.22 10-Q · filed 2020-02-13 | ||||||||
| 2018-09-30 | -$1.17 10-K · filed 2019-12-16 | ||||||||
| 2018-06-30 | -$0.19 10-Q · filed 2018-08-14 | -$0.99 10-Q · filed 2019-08-14 | |||||||
| 2018-03-31 | -$0.44 10-Q · filed 2019-05-15 | -$0.82 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | -$0.38 10-Q · filed 2019-02-14 | ||||||||
| 2017-09-30 | -$1.89 10-K · filed 2019-12-16 | ||||||||
| 2017-06-30 | -$0.48 10-Q · filed 2018-08-14 | -$0.49 10-Q · filed 2017-08-14 | -$1.47 10-Q · filed 2018-08-14 | -$1.45 10-Q · filed 2017-08-14 | |||||
| 2017-03-31 | -$0.55 10-Q · filed 2018-05-11 | -$0.04 10-Q · filed 2017-05-15 | -$0.99 10-Q · filed 2018-05-11 | -$0.07 10-Q · filed 2017-05-15 | |||||
| 2016-12-31 | -$0.44 10-Q · filed 2018-02-14 | -$0.03 10-Q · filed 2017-02-14 | |||||||
| 2016-09-30 | -$2.29 10-K · filed 2018-12-11 | -$0.15 10-K · filed 2016-12-23 | |||||||
| 2016-06-30 | -$0.75 10-Q · filed 2017-08-14 | -$0.05 10-Q · filed 2016-08-15 | -$1.78 10-Q · filed 2017-08-14 | -$0.12 10-Q · filed 2016-08-15 | |||||
| 2016-03-31 | -$0.02 10-Q · filed 2017-05-15 | -$0.06 10-Q · filed 2017-05-15 | |||||||
| 2015-12-31 | -$0.04 10-Q · filed 2017-02-14 | ||||||||
| 2015-09-30 | -$1.37 10-K · filed 2017-12-13 | -$0.09 10-K · filed 2015-12-14 | |||||||
| 2015-06-30 | -$0.03 10-Q · filed 2016-08-15 | -$0.06 10-Q · filed 2016-08-15 | |||||||
| 2015-03-31 | -$0.01 10-Q · filed 2016-05-20 | -$0.04 10-Q · filed 2016-05-20 | |||||||
| 2014-12-31 | -$0.03 10-Q · filed 2016-02-12 | ||||||||
| 2014-09-30 | -$0.04 10-K · filed 2015-12-14 | -$0.04 10-K · filed 2016-12-23 | |||||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-13 | -$0.04 10-Q · filed 2015-08-13 | |||||||
| 2014-03-31 | -$0.01 10-Q · filed 2015-05-13 | -$0.04 10-Q · filed 2015-05-13 | |||||||
| 2013-12-31 | -$0.03 10-Q · filed 2015-02-17 | -$0.07 10-K · filed 2015-12-14 | |||||||
| 2012-12-31 | -$0.06 10-KT · filed 2014-12-29 | ||||||||
| 2011-09-30 | $0.00 10-K · filed 2012-01-13 | ||||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-26 | $0.00 10-Q · filed 2011-08-26 | |||||||
| 2010-09-30 | $0.00 10-K · filed 2012-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |